← Back to Search

Antiretroviral Therapy

Telemedicine & HIV PrEP for Rural HIV Prevention

N/A

Waitlist Available

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial is looking at HIV and STI rates in rural areas and how to best provide access to prevention services in those areas.

Who is the study for?

This trial is for adults over 18 living in rural or frontier counties of Colorado who have internet and a smart device to complete surveys in English or Spanish. It's not for those without internet access, living in urban areas, unable to complete surveys in both languages, or already HIV positive.Check my eligibility

What is being tested?

The study tests the effectiveness of virtual clinical visits with home lab kits and mailed HIV PrEP (pre-exposure prophylaxis) medication as a way to prevent HIV and STI spread among rural residents. Participants will use telemedicine services from the University of Colorado.See study design

What are the potential side effects?

While this summary does not specify side effects related to the interventions being studied (virtual visits and mailed health materials), typical concerns might include privacy issues with online systems, potential miscommunication during virtual visits, and errors in self-administering home lab kits.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Persistence in PrEP care

Secondary outcome measures

Acceptability of Telemedicine visits

Acceptability of postal lab kits

Feasibility of Telemedicine visits

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Telemedicine Clinical CareExperimental Treatment1 Intervention

Rural participants who enter PrEP clinical care with University of Colorado HIV Prevention Program will receive care via telemedicine with mailed lab kits and mailed HIV PrEP.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,734 Previous Clinical Trials

2,148,814 Total Patients Enrolled

Gilead SciencesIndustry Sponsor

1,083 Previous Clinical Trials

843,290 Total Patients Enrolled

Media Library

HIV PrEP (Antiretroviral Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05319613 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: Telemedicine Clinical Care

Human Immunodeficiency Virus Infection Clinical Trial 2023: HIV PrEP Highlights & Side Effects. Trial Name: NCT05319613 — N/A

HIV PrEP (Antiretroviral Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05319613 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research project actively recruiting participants?

"Affirmative, the data on clinicaltrials.gov reveals that this medical experiment is currently seeking volunteers. The trial was first published on March 9th 2020 and its most recent update occured on August 11th 2022; they are recruiting a total of 100 participants from one site."

Answered by AI

What is the total enrolment count for this clinical trial?

"Affirmative. According to clinicaltrials.gov, the trial in question is actively seeking participants; it was initially posted on March 9th 2022 and amended lastly on August 11th 2022. One hundred individuals need to be accepted into the study by one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Reducing Disparities in Rural HIV Prevention

Donna McGregor 2022. "Reducing Disparities in Rural HIV Prevention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05319613.